Gastric Burkitt lymphoma is a distinct subtype that has superior outcomes to other types of Burkitt lymphoma/leukemia

Annals of Hematology

Volumn 85, Issue 5, 2006, Pages 285-290

  Park, Yeon Hee ^a   Kim, Won Seog ^b   Kang, Hye Jin ^a   Na, Im Il ^a   Ryoo, Baek Yeol ^a   Yang, Sung Hyun ^a   Lee, Seung Sook ^a   Uhm, Ji Eun ^b   Kim, Kihyun ^b   Jung, Chul Won ^b   Park, Keunchil ^b   Ko, Young H ^b  

^a Korea Institute of Radiation and Medical Science   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Burkitt lymphoma; Stomach

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; PREDNISOLONE; PREDNISONE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BURKITT LYMPHOMA; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER REGISTRY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG FATALITY; DRUG FEVER; FEMALE; HEALTH SURVEY; HUMAN; IMMUNOPHENOTYPING; LEUKEMIA; LONG TERM CARE; LYMPH NODE METASTASIS; MALE; NEUTROPENIA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; STOMACH ANTRUM; STOMACH LYMPHOMA; SURVIVAL RATE; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BURKITT LYMPHOMA; CHILD; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; REMISSION INDUCTION; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 33646694517     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-005-0050-8     Document Type: Article

References (28)

1. Adde M, Shad A, Venzon D et al (1998) Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomas. Semin Oncol 25:33-39
2. Amer MH, El-Akkad S (1994) Gastrointestinal lymphoma in adults: Clinical features and management of 300 cases. Gastroenterology 106:846-858
3. Bennett J, Catovsky D, Daniel M et al (1985) Proposed revised criteria for the classification of acute myeloid leukemia: A report of the French-American-British Cooperative Group. Ann Intern Med 103:620-625
4. Bernstein J, Coleman C, Strickler J et al (1986) Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt's and non-Burkitt's types). J Clin Oncol 4:847-858
5. Binn M, Ruskone-Fourmestraux A, Lepage E, Haioun C, Delmer A, Aegerter P et al (2003) Surgical resection plus chemotherapy versus chemotherapy alone: Comparison of two strategies to treat diffuse large B-cell gastric lymphoma. Ann Oncol 14:1751-1757
6. Blum KA, Lozanski G, Byrd JC (2004) Adult Burkitt leukemia and lymphoma. Blood 104:3009-3020
7. Cabanillas M, Thomas D, Cortes J et al (2003) Outcome with hyper-CVAD and rituximab in Burkitt (BL) and Burkitt-like (BLL) leukemia/lymphoma. Proc Am Soc Clin Oncol 22:2309 (abstract)
8. Crump M, Gospodarowicz M, Shepherd FA (1999) Lymphoma of the gastrointestinal tract. Semin Oncol 26:324-337
9. d'Amore F, Christensen BE, Brincker H et al (1991) Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Eur J Cancer 27:1201-1208
10. Divine M, Lepage E, Briere J et al (1996) Is the small non-cleaved cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case controlled analysis. J Clin Oncol 24:240-248
11. Divine M, Cassasus P, Koscielny S et al (2000) Adult Burkitt lymphoma. A prospective multicenter trial with the LMB protocol. Proc Am Soc Clin Oncol 19:80 (abstract)
12. Dragosics B, Baur P, Radaszkiewicz T (1985) Primary gastrointestinal non-Hodgkin's lymphomas. A retrospective clinicopathological study of 150 cases. Cancer 55:1060-1073
13. Gurney KA, Cartwright RA, Gilman EA (1999) Descriptive epidemiology of gastrointestinal non-Hodgkin's lymphoma in a population-based registry. Br J Cancer 79:1929-1934
14. Jaffe ES, Harris NL, Stein H, Vardiman JW (2001) World Health Organization classification of tumours; tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon
15. Ko YH, Kim CW, Park CS, Jang HK, Lee SS, Kim SH et al (1998) REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma. Cancer 83:806-812
16. Koch P, del Valle F, Berdel WE, Willich NA, Reers B, Hiddemann W et al (2001) German Multicenter Study Group. Primary gastrointestinal non-Hodgkin's lymphoma: I. anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol 19:3861-3873
17. Krugmann J, Tzankov A, Fiegl M et al (2004) Burkitt's lymphoma of the stomach: A case report with molecular cytogenetic analysis. Leuk Lymphoma 45:1055-1059
18. LaCasce A, Howard O, Li S et al (2003) The Magrath regimen is effective in older adults with Burkitt's and Burkitt-like lymphomas. Proc Am Soc Clin Oncol 21:1150 (abstract)
19. Lee E, Pertroni G, Schiffer C et al (2001) Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma: Results of cancer and leukemia group B study 9251. J Clin Oncol 19:4014-4022
20. Liu HT, Hsu C, Chen CL, Choang IP, Chen LT, Chen YC et al (2000) Chemotherapy alone versus surgery followed by chemotherapy for stage I/ IIE large-cell lymphoma of the stomach. Am J Hematol 64:175-179
21. Longo D, Duffey P, Jaffe E et al (1994) Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: A high-grade lymphoma responsive to ProMACE-based combination therapy. J Clin Oncol 12:2153-2159
22. Lopez T, Hagemeister F, McLaughlin P et al (1990) Small noncleaved cell lymphoma in adults: Superior results for stages I-III disease. J Clin Oncol 8:615-622
23. Magrath I, Adde M, Shad A, Venzon D, Seibel N, Gootenberg J, Neely J, Arndt C, Nieder M, Jaffe E, Wittes RA, Horak ID (1996) Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol 14:925-934
24. Müller MB, Pedersen NT, Christensen BE (2004) Diffuse large B-cell lymphoma: Clinical implications of extranodal versus nodal presentation - a population-based study of 1575 cases. Br J Haematol 124:151-159
25. Nakamura S, Akazawa K, Yao K et al (1995) Primary gastric lymphoma - a clinicopathologic study of 233 cases with special reference to evaluation with the MIB-1 index. Cancer 76:1313-1325
26. Philip T, Meckenstock R, Deconnick E et al (1992) Treatment of poor prognosis Burkitt's lymphoma in adults with the Societe Francaise d'Oncologie Pediatrique LMB protocol - a study of the Federation Nationale des Centres de Lutte Contre le Cancer (FNLCC). Eur J Cancer 28A:1954-1959
27. Raderer M, Valencak J, Osterreicher C, Drach J, Hejna M, Kornek G et al (2000) Chemotherapy for the treatment of patients with primary high grade gastric B-cell lymphoma of modified Ann Arbor stages IE and IIE. Cancer 88: 1979-1985
28. Todeschini G, Tecchio C, Dagani D et al (1997) Eighty-one percent event-free survival in advanced Burkitt's lymphoma/leukemia: No differences in outcome between pediatric and adult patients treated with the same intensive pediatric protocol. Ann Oncol 8:S77-S81